| Dr Oliver F Adunka, MD | |
|
915 Olentangy River Rd, Columbus, OH 43212-3153 | |
| (614) 366-3687 | |
| (614) 293-3193 |
| Full Name | Dr Oliver F Adunka |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 25 Years |
| Location | 915 Olentangy River Rd, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316975444 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 200600334 (North Carolina) | Secondary |
| 207Y00000X | Otolaryngology | 35123953 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohio State University State Health System | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osu Otolaryngology Head And Neck Surgery Llc | 9830114529 | 59 |
News Archive
"SWOG always brings an impressive portfolio of work to the ASCO annual meeting," said SWOG Chair Charles D. Blanke, MD, "and this year I'm particularly excited about the research our investigators are presenting because it includes results that are likely to be practice-changing."
Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.
Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project "FLUCURE" supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses.
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
› Verified 2 days ago
| Entity Name | Children's Surgical Associates, Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417905324 PECOS PAC ID: 1254328511 Enrollment ID: O20040428000888 |
News Archive
"SWOG always brings an impressive portfolio of work to the ASCO annual meeting," said SWOG Chair Charles D. Blanke, MD, "and this year I'm particularly excited about the research our investigators are presenting because it includes results that are likely to be practice-changing."
Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.
Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project "FLUCURE" supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses.
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
› Verified 2 days ago
| Entity Name | Osu Otolaryngology Head And Neck Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861449407 PECOS PAC ID: 9830114529 Enrollment ID: O20051012000007 |
News Archive
"SWOG always brings an impressive portfolio of work to the ASCO annual meeting," said SWOG Chair Charles D. Blanke, MD, "and this year I'm particularly excited about the research our investigators are presenting because it includes results that are likely to be practice-changing."
Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.
Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project "FLUCURE" supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses.
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Oliver F Adunka, MD 915 Olentangy River Rd, Columbus, OH 43212-3153 Ph: (614) 366-3687 | Dr Oliver F Adunka, MD 915 Olentangy River Rd, Columbus, OH 43212-3153 Ph: (614) 366-3687 |
News Archive
"SWOG always brings an impressive portfolio of work to the ASCO annual meeting," said SWOG Chair Charles D. Blanke, MD, "and this year I'm particularly excited about the research our investigators are presenting because it includes results that are likely to be practice-changing."
Current treatments for tuberculosis are very effective in controlling TB infection caused by Mycobacterium tuberculosis. They don't, however, always prevent reinfection. Why this happens is one of the long-standing questions in TB research.
Pharmacelsus GmbH announces its participation in the 4 year multi-national research cooperation project "FLUCURE" supported by the European Union with the goal of developing novel, small molecule based therapeutics for respiratory diseases caused by influenza viruses.
Cancer researchers at Intermountain Medical Center and the Intermountain Precision Genomics Program in Salt Lake City are launching an exciting, new three-year study to determine if a blood test that looks for DNA from a cancer tumor can be used to complement mammography to improve the way breast cancer is diagnosed.
› Verified 2 days ago
Alexander Nelson Rock, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 915 Olentangy River Rd Ste 4000, Columbus, OH 43212 Phone: 614-293-9215 Fax: 614-293-1923 | |
Naomi Rabinovics, Otolaryngology Medicare: Medicare Enrolled Practice Location: 915 Olentangy River Rd, Columbus, OH 43212 Phone: 614-293-9215 Fax: 614-293-1923 | |
Taylor Elaine Freeman, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 915 Olentangy River Rd Ste 4000, Columbus, OH 43212 Phone: 614-293-9215 Fax: 614-293-1923 | |
Subinoy Das, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 770 Jasonway Ave Ste 1b, Columbus, OH 43214 Phone: 614-867-3681 Fax: 614-914-5025 | |
Ryan John Ivancic, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 915 Olentangy River Rd Ste 4000, Columbus, OH 43212 Phone: 614-293-9215 Fax: 614-293-1923 | |
Dr. Amit Agrawal, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave Fl 5, Columbus, OH 43210 Phone: 614-293-8074 Fax: 614-293-3193 | |
Karen Hall Calhoun, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 915 Olentangy River Rd, Suite 4000, Columbus, OH 43212 Phone: 614-366-3687 Fax: 614-293-6176 |